FLXN Stock Surged 4.77%. Here’s What You Should Know
Flexion Therapeutics, Inc. (FLXN) is up 4.77% during pre-market trading at the price of $5.71 after the release of Phase-II Pharmacokinetics (PK) results. Publication of Results from Phase-2 Pharmacokinetics: FLXN, on 9th August 2021, disclosed that the results from the Phase 2 Pharmacokinetic (open-label) trial of ZILRETTA were released in R&D Drugs. The plasma PK […]
